FDA NDC Directory · JSON-LD · Markdown

NALOXONE HCI

NDC 51662-1242 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerHF Acquisition Co. LLC, DBA Health First
Marketing categoryAbbreviated NDA (generic) · App ANDA070256
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active ingredientsNALOXONE HYDROCHLORIDE (.4 mg/mL)
Marketing started20180818
Package count2

External sources

Source: openFDA. Public-domain (CC0).